Sildenafil
Product Images NDC 68071-2689

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 68071-2689). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2689 3)

Sildenafil 25 mg tablets bottle label from NuCare Pharmaceuticals, Inc., containing 30 tablets. Manufactured by Hetero Labs Limited, Hyderabad, India. The label shows NDC 68071-2689-3 with product number R1901030. Includes storage instructions to keep at controlled temperature 68-77°F and a warning to keep out of reach of children.*

FDA Label Image

Camberlogo1 (Camberlogo1)

FDA Label Image

Camberlogo2 (Camberlogo2)

FDA Label Image

Sildenafilfigure7 (Sildenafilfigure7)

A bar chart showing the percentage of patients reporting improvement by treatment group. The groups include Placebo and Sildenafil Citrate Tablets at 25 mg, 50 mg, and 100 mg doses, with increasing improvement percentages from 24% for Placebo to 82% for 100 mg Sildenafil Citrate Tablets.*

FDA Label Image

Sildenafilfigure1 (Sildenafilfigure1)

A line graph comparing the effect of Sildenafil 100mg and placebo on systolic blood pressure (mmHg) over 24 hours post dose. The x-axis represents time post dose (hours) and the y-axis represents systolic blood pressure changes. Data points for Sildenafil and placebo show fluctuating values within this period.*

FDA Label Image

Sildenafilfigure2 (Sildenafilfigure2)

A line graph comparing the change in a measured variable over time for two treatments: Docamis and Placebo, and Docamis with Cilostazol 1.25 mg. The x-axis shows time in hours postdose, and the y-axis shows the change from baseline. Data points for each treatment are connected by lines with different markers.*

FDA Label Image

Sildenafilfigure3 (Sildenafilfigure3)

A line graph showing the percent change in a variable over time postdose (hours). It compares two treatments: Doxazosin in Plantaris muscle and Doxazosin with Sildenafil 50 mg. Data points are plotted with distinct symbols for each treatment and connected by lines over an 8-hour period.*

FDA Label Image

Sildenafilfigure4 (Sildenafilfigure4)

A line graph depicting mean change in a variable over time after dosing for two groups: Doxazosin with Sildenafil 100 mg and Doxazosin with Placebo. The x-axis represents time after dosing in hours (0 to 8), and the y-axis represents the measured change in millimeters of mercury (mmHg). Both groups show an initial decline followed by a gradual return toward baseline over 8 hours.*

FDA Label Image

Sildenafilfigure5 (Sildenafilfigure5)

A pharmacokinetic curve showing serum concentration (ng/mL) versus time post dose (hours) for Sildenafil. The graph plots concentration levels from 0 to 24 hours after administration of a commercial tablet formulation by NuCare Pharmaceuticals,Inc. Concentration peaks early then declines over time.*

FDA Label Image

Sildenafilfigure6a (Sildenafilfigure6a)

A bar chart depicting the percentage of patients at endpoint categorized by baseline scores from 0 to 5. The bars are segmented into six groups labeled 0 through 5, showing varying percentages of patients across the baseline scores.*

FDA Label Image

Sildenafilfigure6b (Sildenafilfigure6b)

A bar chart illustrating the distribution of baseline scores versus the percentage of patients at the endpoint. The x-axis represents baseline scores ranging from 0 to 5, while the y-axis shows the percentage of patients. The chart includes multiple bars for each baseline score, each corresponding to a different categorical variable labeled from 00 to 05 in the legend on the right.*

FDA Label Image

Sildenafilheterologo1 (Sildenafilheterologo1)

FDA Label Image

Sildenafilheterologo2 (Sildenafilheterologo2)

FDA Label Image

Sildenafilstructure (Sildenafilstructure)

Chemical structure of sildenafil citrate showing the arrangement of atoms and functional groups in the active ingredient molecule.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.